Related references
Note: Only part of the references are listed.Role of insulin resistance on fertility – Focus on polycystic ovary syndrome
Camille Vatier et al.
ANNALES D ENDOCRINOLOGIE (2022)
Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
Chandna Vasandani et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2022)
Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance
Isabel Huang-Doran et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
PPAR control of metabolism and cardiovascular functions
David Montaigne et al.
NATURE REVIEWS CARDIOLOGY (2021)
Peroxisome proliferator-activated receptor gamma-ligand-binding domain mutations associated with familial partial lipodystrophy type 3 disrupt human trophoblast fusion and fibroblast migration
Hussein Shoaito et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Pharmacological activation of peroxisome proliferator-activated receptor γ (PPAR-γ) protects against hypoxia-associated fetal growth restriction
Sydney L. Lane et al.
FASEB JOURNAL (2019)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
HUMAN REPRODUCTION (2018)
Abruptio placentae risk and genetic variations in mitochondrial biogenesis and oxidative phosphorylation: replication of a candidate gene association study
Tsegaselassie Workalemahu et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
The Rotterdam Study: 2018 update on objectives, design and main results
M. Arfan Ikram et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2017)
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
Rebecca J. Brown et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Prospective functional classification of all possible missense variants in PPARG
Amit R. Majithia et al.
NATURE GENETICS (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinelli-Seip syndrome
D. A. Dyment et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2014)
Pathway Analysis of Genetic Factors Associated with Spontaneous Preterm Birth and Pre-Labor Preterm Rupture of Membranes
Antonio Capece et al.
PLOS ONE (2014)
Peroxisome Proliferator-Activated Receptor-γ Mutations Responsible for Lipodystrophy With Severe Hypertension Activate the Cellular Renin-Angiotensin System
Martine Auclair et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Prevalence of Reproductive Abnormalities Among Women with Familial Partial Lipodystrophy
Tisha Joy et al.
Endocrine Practice (2013)
Vascular placental abnormalities and newborn death in a pregnant diabetic woman with familial partial lipodystrophy type 3: A possible role for peroxisome proliferator-activated receptor γ
A. L. Castell et al.
DIABETES & METABOLISM (2012)
A complicated pregnancy in a patient with lipodystrophic diabetes attributable to a peroxisome proliferator-activated receptor gamma (PPARG) mutation
M. Madhra et al.
DIABETIC MEDICINE (2012)
Regulation of the Human Endogenous Retroviral Syncytin-1 and Cell-Cell Fusion by the Nuclear Hormone Receptors PPARγ/RXRα in Placentogenesis
Matthias Ruebner et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Placental Expression of Peroxisome Proliferator-Activated Receptor γ (PPARγ): Relation to Placental and Fetal Growth
Marta Diaz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
PPARγ and human trophoblast differentiation
Thierry Fournier et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2011)
PPARγ in Placental Angiogenesis
Karim Nadra et al.
ENDOCRINOLOGY (2010)
Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: Gestational diabetes mellitus, intrauterine growth restriction and preeclampsia
S. J. Holdsworth-Carson et al.
PLACENTA (2010)
Lipodystrophy An Unusual Diagnosis in a Case of Oligomenorrhea and Hirsutism
Jennifer Keller et al.
OBSTETRICS AND GYNECOLOGY (2009)
Fat and beyond: The diverse biology of PPAR gamma
Peter Tontonoz et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Interference with PPARγ function in smooth muscle causes vascular dysfunction and hypertension
Carmen M. Halabi et al.
CELL METABOLISM (2008)
PPARγ and Early Human Placental Development
Thierry Fournier et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy
M. C. Vantyghem et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Impaired peroxisome proliferator-activated receptor γ function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy
Ellen H. Jeninga et al.
MOLECULAR ENDOCRINOLOGY (2007)
PPARγ and human metabolic disease
RK Semple et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
